MACK
Merrimack Pharmaceuticals, Inc.
MACK
MACK
Delisted
MACK was delisted on the 17th of May, 2024.
76 hedge funds and large institutions have $31.4M invested in Merrimack Pharmaceuticals, Inc. in 2018 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 21 increasing their positions, 20 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
76
Holders Change
-5
Holders Change %
-6.17%
% of All Funds
1.74%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
21
Reduced
20
Closed
20
Calls
$1.63M
Puts
$352K
Net Calls
+$1.28M
Net Calls Change
+$1.04M
Top Buyers
| 1 |
BI
BVF Inc
San Francisco,
California
|
$5.45M |
| 2 |
NM
Newtyn Management
New York
|
$3.11M |
| 3 |
WIM
Wittenberg Investment Management
Carlisle,
Massachusetts
|
$1.25M |
| 4 |
Goldman Sachs
New York
|
$669K |
| 5 |
JGC
J. Goldman & Co
New York
|
$491K |
